"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)"
NODAT-ES
1 other identifier
interventional
210
1 country
1
Brief Summary
Introduction: Diabetes is a chronic disease that requires lifelong self care behavior. Successful treatment of chronic diseases is closely associated with the education of both patients and their relatives. Patient education is one of the most important responsibilities of diabetes nurse educators. In the management of diabetes, helping patients to improve their health and quality of life is considered an important aspect of diabetes self-care education. Solid organ transplantation is now the standard of care for end-stage organ failure. New-onset diabetes mellitus after solid organ transplantation (NODAT) has emerged as an increasingly important determinant of outcomes and survival in transplant recipients. Patient education and self-management are crucial for ensuring successful outcome post transplantation. No adequate studies concerning education of diabetic renal transplants. Aim of the work: The aim of this work is to evaluate the effect of diabetes education given to renal transplant recipients with new onset diabetes after transplantation (NODAT) on their self-care activities and metabolic control variables and reversibility of the present chronic diabetic complications. Patients and methods: The study will involve 210 diabetic renal transplant patients (NODAT) who will be referred from Hamed Al-Essa organ transplant center to Dasman Diabetes Institute. These patients will be sub-divided into three subgroups: patients who will receive group education (n=70) will represent group1, patients who will receive one to one education (n=70) will represent group 2, while those who will receive the conventional (not structured) education program will serve as control group 3(n= 70). All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed. Expected outcome: Patient education given to transplant recipients with NODAT could affect patients' self-care activities, metabolic control positively and possibly help in reversal of chronic diabetic complications
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedFirst Posted
Study publicly available on registry
July 23, 2019
CompletedJuly 23, 2019
July 1, 2019
3.1 years
March 15, 2017
July 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the effect of diabetes education given to renal transplant recipients with new onset diabetes after transplantation .
Positive metabolic control and self-care diabetes management
For 2 years from the time of enrolment
Secondary Outcomes (1)
comparison of type of diabetes education
For 2 years from the enrolment
Study Arms (3)
Group education for 2 years
ACTIVE COMPARATORPatients who will receive structured diabetes education in groups , Group 1
One to one education for 2 years
ACTIVE COMPARATORPatients who will receive one to one structured diabetes education, Group 2
Control group without structured education
NO INTERVENTIONPatients who will not receive structured diabetes education, Group 3
Interventions
All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
Eligibility Criteria
You may qualify if:
- \) transplant duration more than 6 months; 2) being an outpatient; 3) not having any psychiatric history of illness; 4) written consent to participate in the research; and 5) age of diabetic patients more than 21 years
You may not qualify if:
- pediatrics (bellow 21years) and mentally abnormal patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dasman diabetes institute
Kuwait City, Kuwait City, 15462, Kuwait
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nashwa F Othman, MD PhD
Senior diabetes educator in Dasman Diabetes Institute
- STUDY DIRECTOR
Osama A Gheith, MD PhD
Consultant nephrologist, Hamed Al-Essa organ transplnat center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior specialist diabetes educator
Study Record Dates
First Submitted
March 15, 2017
First Posted
July 23, 2019
Study Start
May 1, 2015
Primary Completion
June 1, 2018
Study Completion
July 1, 2019
Last Updated
July 23, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share